Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : GHIT Fund
Deal Size : $0.8 million
Deal Type : Funding
GHIT Fund Announces New Investments in a Lead Optimization trial for Soil-transmitted helminths Drug
Details : Funds will be used for Cry5B optimization for Trichuris - whipworm which is beign conducted by Kao Corporation, PATH, University of Massachusetts Medical School.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
September 29, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : GHIT Fund
Deal Size : $0.8 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?
Reset All
